Can we increase the cure rate of adults with acute lymphoblastic leukemia?

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Leukemia & lymphoma·2016

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Leukemia & lymphoma·2016

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia.

Leukemia research·2012

Management of refractory acute myeloid leukemia: re-induction therapy or straight to transplantation?

Current hematologic malignancy reports·2011

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2011

Farnesyltransferase inhibitors in myelodysplastic syndrome.

Current hematologic malignancy reports·2010

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Leukemia·2026

Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.

Leukemia·2026

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

Leukemia·2026

Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy.

Leukemia·2026

KLF4/MLL3 complex axis drives NRBP2 transcription to eliminate acute myeloid leukemia cells.

Leukemia·2026

Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

Leukemia·2026

4D nucleome landscape reveals dissolution of bipartite active X chromosome in liver cancer development.

Nature cell biology·2026

Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

Blood cancer journal·2026

Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis.

European journal of haematology·2026

Transcription elongation by RNA polymerase II: from regulatory complexity to disease.

Trends in cell biology·2026

Modulation of X-irradiation-induced γ-H2AX focus stability in human blood lymphocytes: A technical note.

Mutation research. Genetic toxicology and environmental mutagenesis·2026

Effect of Prior Hilar Manipulation During Previous Hepatectomy on Surgical Outcomes of Laparoscopic Repeat Hepatectomy.

Asian journal of endoscopic surgery·2026

Related Experiment Videos

Can we increase the cure rate of adults with acute lymphoblastic leukemia?

Related Concept Videos

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia.

Management of refractory acute myeloid leukemia: re-induction therapy or straight to transplantation?

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.

Farnesyltransferase inhibitors in myelodysplastic syndrome.

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia.

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy.

KLF4/MLL3 complex axis drives NRBP2 transcription to eliminate acute myeloid leukemia cells.

Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

4D nucleome landscape reveals dissolution of bipartite active X chromosome in liver cancer development.

Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis.

Transcription elongation by RNA polymerase II: from regulatory complexity to disease.

Modulation of X-irradiation-induced γ-H2AX focus stability in human blood lymphocytes: A technical note.

Effect of Prior Hilar Manipulation During Previous Hepatectomy on Surgical Outcomes of Laparoscopic Repeat Hepatectomy.

Related Experiment Videos

Can we increase the cure rate of adults with acute lymphoblastic leukemia?

Related Concept Videos

Related Articles